CD4 and lung carcinoma: The results of CD160 were similar to the results of Bioxin, with high expression on CD8+ T cells and NK cells, in addition to CD4+ T cells in colorectal cancer, which was not observed in breast and lung cancer (Figures 4G, 5G, 6G).